SenesTech (SNES) director receives 100,000 stock options vesting over 1 year

Rhea-AI Filing Summary

SenesTech, Inc. director Jamie Bechtel Morrison received a grant of stock options covering 100,000 shares of common stock. The options have an exercise price of $1.6500 per share and expire on June 15, 2036. According to a footnote, the award vests monthly over one year in 12 equal installments, providing compensation that aligns the director’s incentives with long-term shareholder value. Following this grant, the filing shows 100,000 derivative securities held directly, and no sales or exercises were reported in this filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Morrison Jamie Bechtel

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	100,000	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 100,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 100,000 options Exercise price: $1.6500 per share Underlying shares: 100,000 shares +3 more

6 metrics

Option grant size 100,000 options Stock Option (right to buy) granted to director

Exercise price $1.6500 per share Conversion or exercise price of options

Underlying shares 100,000 shares Underlying SenesTech common stock

Expiration date June 15, 2036 Option expiration

Holdings after grant 100,000 derivative securities Total options held following transaction

Vesting schedule 12 monthly installments over 1 year Footnote description of vesting

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, derivative securities, underlying security, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

derivative securities financial

"derivativeTransactionCount: 1 derivative-type record"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

underlying security financial

"underlying_security_title: Common Stock"

vesting financial

"Monthly over 1 year (12 equal monthly installments)"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morrison Jamie Bechtel

(Last) (First) (Middle)

C/O SENESTECH, INC.

13430 N DYSART RD STE 105

(Street)

SURPRISE ARIZONA 85379

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SenesTech, Inc. [ SNES ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$1.65	06/15/2026		A		100,000		07/15/2026(1)	06/15/2036	Common Stock	100,000	$0	100,000	D

Explanation of Responses:

1. Monthly over 1 year (12 equal monthly installments)

Remarks:

	/s/ Thomas C. Chesterman, Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did SenesTech (SNES) disclose in this Form 4 for Jamie Bechtel Morrison?

SenesTech disclosed that director Jamie Bechtel Morrison received a grant of stock options for 100,000 shares of common stock. These options form part of her equity-based compensation and are intended to align her interests with those of other shareholders over time.

How many stock options did the SenesTech director receive in this filing?

The director received stock options covering 100,000 shares of SenesTech common stock. This entire option position is shown as held directly after the transaction, with no accompanying sales or exercises reported in the same Form 4 filing.

What is the exercise price and expiration date of the new SenesTech options?

The options carry an exercise price of $1.6500 per share and expire on June 15, 2036. This means the director can choose to buy shares at $1.6500 up until that expiration date, subject to the options vesting over time.

How do the SenesTech stock options granted to the director vest?

A footnote states the options vest monthly over one year in 12 equal installments. This structure gradually delivers the award, encouraging the director’s continued service and alignment with SenesTech’s performance throughout the first year after the grant date.

Did the SenesTech director sell or buy any common shares in this Form 4?

No open-market purchases or sales of common shares were reported. The only transaction was an acquisition of derivative securities through an option grant, so there is no change in common stock holdings from market trading in this particular filing.

What is Jamie Bechtel Morrison’s option position after this SenesTech grant?

After the grant, the Form 4 shows the director holding 100,000 derivative securities related to stock options. These options are held directly and reference 100,000 underlying shares of common stock, with no remaining derivative positions beyond this grant listed.